Simplex Trading
HEPA

Simplex Trading’s Hepion Pharmaceuticals HEPA Stock Holding History

Simplex Trading’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-105
Closed -$81K – 9350
2023
Q1 		$81K Buy
105
+24
+30% +$17.7K ﹤0.01% 5398
2022
Q4 		$24K Hold
81
– – ﹤0.01% 6684
2022
Q3 		$41K Sell
81
-27
-25% -$16.5K ﹤0.01% 6701
2022
Q2 		$61K Sell
108
-64
-37% -$53.3K ﹤0.01% 6228
2022
Q1 		$221K Buy
172
+32
+23% +$35.4K ﹤0.01% 5023
2021
Q4 		$159K Buy
140
+39
+39% +$53.4K ﹤0.01% 5507
2021
Q3 		$212K Sell
101
-1
-1% -$1.6K ﹤0.01% 5500
2021
Q2 		$202K Buy
102
+101
+10,100% +$185K ﹤0.01% 5664
2021
Q1 		$144K Hold
1
– – ﹤0.01% 5238
2020
Q4 		$225K Buy
+1
New +$2.59K ﹤0.01% 4450

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return